Old Mission Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Old Mission Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-490	Closed	-$338K	–	1685
2022 Q3	$338K	Buy	+490	New	+$308K	0.01%	664
2022 Q2	–	Sell	-6,614	Closed	-$4.62M	–	1725
2022 Q1	$4.62M	Buy	+6,614	New	+$4.18M	0.13%	125
2019 Q1	–	Sell	-562	Closed	-$210K	–	319
2018 Q4	$210K	Buy	+562	New	+$206K	0.02%	261
2018 Q1	–	Sell	-1,118	Closed	-$420K	–	500
2017 Q4	$420K	Buy	+1,118	New	+$453K	0.03%	260

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Old Mission Capital's REGN Position: Q4 2022 in Review

Old Mission Capital sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 490 shares — an estimated $338K sold.

Old Mission Capital first reported a position in REGN in Q4 2017 and held it in 4 quarters. The position peaked at $4.62M in Q1 2022. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

Old Mission Capital reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Old Mission Capital sold 490 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $338K.
Old Mission Capital first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 4 quarters.
Old Mission Capital's Regeneron Pharmaceuticals position peaked at $4.62M in Q1 2022.
1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Old Mission Capital's 13F filing for Q4 2022, filed 14 Feb 2023.